G oing into detail - MIN | Mohamed Ibrahim NoordinG oing into detail Theoritical C oncept of,...

21
Going in to detail T h e o ritic a l C o n c e p t o f, T a b le ttin g p ro c e s s , P rocedures a n d Characteristic

Transcript of G oing into detail - MIN | Mohamed Ibrahim NoordinG oing into detail Theoritical C oncept of,...

Page 1: G oing into detail - MIN | Mohamed Ibrahim NoordinG oing into detail Theoritical C oncept of, Tabletting process, Procedures and C haracteristic. ACTIVE ... The goals in tablet dosage

G o in g in t o d e ta i l

T h e o r i t ic a l C o n c e p t o f ,

T a b le t t in g p r o c e s s , P r o c e d u r e s a n d C h a r a c te r is t ic

Page 2: G oing into detail - MIN | Mohamed Ibrahim NoordinG oing into detail Theoritical C oncept of, Tabletting process, Procedures and C haracteristic. ACTIVE ... The goals in tablet dosage

A C T IV E IN G R E D IE N T

Page 3: G oing into detail - MIN | Mohamed Ibrahim NoordinG oing into detail Theoritical C oncept of, Tabletting process, Procedures and C haracteristic. ACTIVE ... The goals in tablet dosage

T a b le t s : A c t iv e In g r e d ie n t s

2 b r o a d c la s e s o f d r u g , a d m in is t e r e d o r a l ly in fo rm o f ta b le t s :

• (a ) Insoluble drugs in t e n d e d fo r lo c a l e f f e c t o n G ITe g ., a b s o r b e n t a n d a n ta c id

• (b ) S oluble drugs in t e n d e d fo r s y s t e m ic e f f e c t f o l lo w in g d is s o lu t io n in G IT a n d s u b s e q u e n t a b s o r p t io n

Page 4: G oing into detail - MIN | Mohamed Ibrahim NoordinG oing into detail Theoritical C oncept of, Tabletting process, Procedures and C haracteristic. ACTIVE ... The goals in tablet dosage

T h e g o a ls in ta b le t d o s a g e fo rm d e s ig n fo r th e 2 c la s s e s d i f f e r .

• Insoluble drugs - a c t io n a r e s t r o n g ly e f f e c t e d b y s u r f a c e p h e n o m e n a s o th e p r o d u c t d e s ig n s h o u ld c o n s id e r a fo rm u la t io n o f r e a d i ly d is p e r s ib le w i t h f in e p a r t ic le s a n d la r g e s u fa c e a r e a .

• S oluble drugs - fo r s y s t e m ic e f f e c t p r o d u c t n e e d s to d is in t e g r a te a n d d is s o lv e fo r th e r e le a s e o f d r u g in a n a v a i la b le fo rm a t o r a b o v e a b s o r p t io n s i t e . E g .,f o r a d r u g l ik e ly t o b e a b s o r b e d h ig h in th e u p p e r p a r t o f G IT --- d is s o lu t io n n e e d to b e r a p id . F o r p r o d u c t n e e d to d e a b s o r b e d in th e in t e s t in e , i t n e e d to s k ip th e s to m a c h . E g .,a c id la b i le d r u g s ---e n te r ic c o a te d o r o th e r f o rm o f g a s t r ic p r o t e c t io n .

Page 5: G oing into detail - MIN | Mohamed Ibrahim NoordinG oing into detail Theoritical C oncept of, Tabletting process, Procedures and C haracteristic. ACTIVE ... The goals in tablet dosage

C h e m ic a l c h a r a c te r is t ic o f a c t iv e in g r e d ie n t is c r i t ic a l t o p r o d u c t d e s ig n . E g ., I b u p r o fe n :

• E ta n o l c r y s t a l is e d (e th y l) Ib u p r o fe n w a s in i t ia l ly d e v e lo p e d b u t th is c h e m ic a l f o rm is p o o r ly c o m p r e s s ib le , n e e d w e t g r a n u la t io n , te n d e n c y to s t ic k la m in a te d u r in g c o m p r e s s io n .

• M e ta n o l c r y s t a l l is e d (m e th y l) Ib u p r o f e n w a s s u b s e q u e n t ly d e v e lo p e d a n d th is fo rm c a n b e e a s i ly d i r e c t c o m p r e s s w i t h o u t p ic k in g , s t ic k in g a n d la m in a t in g .

Page 6: G oing into detail - MIN | Mohamed Ibrahim NoordinG oing into detail Theoritical C oncept of, Tabletting process, Procedures and C haracteristic. ACTIVE ... The goals in tablet dosage

I n f lu e n c e o f P h y s ic a l P r o p e r t ie s

• s m a l l b a t c h o f s a m p le g iv e n e a r l ie r t o a fo rm u la t o r m a y f r e q u e n t ly d i f f e r f r o m th e la r g e b a t c h m a n u fa c t u r e d la t e r .

• A lm o s t a l l t a b le t s w i l l r e q u i r e d t h e a d d i t io n o f e x c ip ie n t . O th e r th a n fo r t h e p u r p o s e o f s a t is f a c t o r y d r u g r e le a s e a n d fa c i l i t a t e m a n u fa c t u r in g , th e a d d i t io n o f s u c h e x c ip ie n t is to a c h iv e a c c e p t a b le f iz ik a l a n d m e c h a n ic a l p r o p e r t ie s

• T h e C r y s t a l l in e s t r u c t u r e ; f r o m m a n u fa c t u r in g (ta b le t t in g ) a s p e c t , i f a s u b s t a n c e p o s s e s th e p r o p e r crystalline structure i t c a n b e c o m p r e s s e d d i r e c t ly w i t h o u t f u r t h e r t r e a tm e n t . R e la t iv e ly v e r y f e w o f s u c h m a te r ia o (a c t iv e o r e x c ip ie n t) is a v a i la b le .

Page 7: G oing into detail - MIN | Mohamed Ibrahim NoordinG oing into detail Theoritical C oncept of, Tabletting process, Procedures and C haracteristic. ACTIVE ... The goals in tablet dosage

• E g .N a C l :h a v in g c u b ic c r y s t a l l in e s t r u c t u r e , w h e r e u p o n c o m p r e s s io n , th e c r y s t a l l a r e f r a c t u r e d a n d f r a g m e n t fo rm a c lo s e -p a c k a r r a n g e m e n t w h ic h r e a d i ly c o n s o l id a t e s o n c o m p r e s s io n . T h e c u b e s t r u c t u r e e n s u r e th a t s t r u c t u r e a lo n g e a c h a x is is th e s a m e th e r e f o r e n o a l l ig n m e n t is n e c e s s a r y fo r io n ic o r v e n d e r w a a ls b o n d in g to o c c u r b e tw e e n in d iv id u a l p a r t ic le .

W h e r e a s e fo r N o n -C u b ic c r y s t a l l in e s t r u c t u r e , r e a l ig n m e n t is n e c e s s a r y , e g ., K C l, w h e r e p a r t ic le s iz e d is t n .,c r y s t a l l s h a p e , b u lk d e n s i t y & m o is t u r e c o n te n t a r e in f lu e n c in f f a c t o r

Page 8: G oing into detail - MIN | Mohamed Ibrahim NoordinG oing into detail Theoritical C oncept of, Tabletting process, Procedures and C haracteristic. ACTIVE ... The goals in tablet dosage

B io a v a i la b i l i t y C o n s id e r a t io n

G e n e r a l ly , t h e r a n k o r d e r o f

v a r io u s d o s a g e fo rm in d e c r e a s in g o r d e r o f d r u g a v a i la b i l i t y is :

T h e r e f o r e , i f a l l f a c t o r b e in g e q u a l, t a b le t s is o n e o f t h e

le a s t b io a v a i la b le fo rm

o f d r u g .

Solution

Fine suspension(dispersion)

Micronised drugsin capsule

UncoatedTablet

Coated Tablet

Page 9: G oing into detail - MIN | Mohamed Ibrahim NoordinG oing into detail Theoritical C oncept of, Tabletting process, Procedures and C haracteristic. ACTIVE ... The goals in tablet dosage

Factor effecting the release of drug from tablets(confine to formulation and process)

Drug Particle sizePotent drug of

limitedsolubility

need to be insmaller size

Granulation processesmethod, type &

amount of granulating agent

& granule size

Tabletdisintegration

mechanism andrate

Disintegrants& Lubricants

type,amount & method of

incorperation

Plus otherformulation

and processingfactor

Page 10: G oing into detail - MIN | Mohamed Ibrahim NoordinG oing into detail Theoritical C oncept of, Tabletting process, Procedures and C haracteristic. ACTIVE ... The goals in tablet dosage

Effect of granule size on the dissolution rate of salicylic acid contained in compressed tablet

020406080

100120140160180

0 10 20 30 40 50TIME (min)

AM

OU

NT

DIS

SOL

VE

D

(mg) 60- to 80- mesh

40- to 60- mesh

Page 11: G oing into detail - MIN | Mohamed Ibrahim NoordinG oing into detail Theoritical C oncept of, Tabletting process, Procedures and C haracteristic. ACTIVE ... The goals in tablet dosage

C o n to h -C o n to h• T h e e f f e c t o f g r a n u le s iz e o n D r u g R e le a s e c le a r ly

s h o w n b y fa c t t h a t s a l ic y l ic a c id g r a n u le s c a n b e in tw o d i f f e r e n t m e s h r a n g e smesh size vs. Particle size range

• T h e e f f e c t o f C o n t r o l R e le a s e ta b . O f T r ip e le n n a m in e H C l (a n t ih is t .) w h e r e th e crystal size have more impact o n g r a n u le s iz e a l t h o u g h b o t h h a v e a f f e c t o n D r u g R e le a s e .

• D r u g s l ik e N i t r o f u r a n t o in (a n t ib io t ic ) n e e d to h a v e o p t im a l p a r t ic le s iz e ~ 1 5 0 m e s h fo r a d e q u a te r e le a s e o f d r u g a n d to minimise the side effect of emesis

Page 12: G oing into detail - MIN | Mohamed Ibrahim NoordinG oing into detail Theoritical C oncept of, Tabletting process, Procedures and C haracteristic. ACTIVE ... The goals in tablet dosage

T h e e f f e c t o f th e p a r t ic le s iz e o f D i lu e n t s

• P a r t ic u la r ly w h e n la r g e a m o u n t a r e u s e d , d i lu e n t s c a n s ig n i f ic a n t ly a f f e c t t h e b io p h a rm a c e u t ic , c h e m ic a l a n d p h y s ic a l p r o p e r t ie s o f t h e f in a l t a b le t

e g ., * in t e r f e r e n c e w i t h d r u g a b s o r p t io n -C a s a l t in t e r a c t w i t h T e t r a c y c l in e

* d is c o lo r a t io n o f t a b le t -a m in e b a s e s /s a l t s in t e r a c t w i t h la c t o s e in th e p r e s e n c e o f a lk a l in e lu b r ic a n t

• T h e r e f o r e d i lu e n t s h a v e to b e s c r e e n e d f o r in te r a c t io n w i t h in th e ta b le t

Page 13: G oing into detail - MIN | Mohamed Ibrahim NoordinG oing into detail Theoritical C oncept of, Tabletting process, Procedures and C haracteristic. ACTIVE ... The goals in tablet dosage

M o is t u r e C o n te n t a n d U p ta k e b y ta b le t

T h e ty p e o f D i lu e n t s u s e d in a ta b le t w i l l d e te rm in e

• I n i t ia l m o is t u r e le v e l

• T e n d e n c y to r e t a in e d o r p ic k u p m o is t u r e

T h e s e c o n t r ib u t e to p r o d u c t s ta b i l i t y

Page 14: G oing into detail - MIN | Mohamed Ibrahim NoordinG oing into detail Theoritical C oncept of, Tabletting process, Procedures and C haracteristic. ACTIVE ... The goals in tablet dosage

F ig . 2 :

% m o is t u r e u p ta k e b y ta b le t s c o n t a in in g v a r io u s e x c ip ie n t s

Page 15: G oing into detail - MIN | Mohamed Ibrahim NoordinG oing into detail Theoritical C oncept of, Tabletting process, Procedures and C haracteristic. ACTIVE ... The goals in tablet dosage

H o w th e h y g r s c o p ic n a tu r e o f e x c ip ie n t c a n a f f e c t t h e ta b le t f o rm u la t io n

• W a te r s o r p t io n o r d e s o r p t io n b y d r u g s a n d e x c ip ie n t s is n o t a lw a y s r e v e r s ib le . A b s o r b e d m o is t u r e m a y n o t b e e a s i ly r e m o v e d d u r in g d r y in g .

• M o is t u r e c a n e f f e c t t b e w a y in w h ic h a s y s t e m a c c e p t s e q u o u s g r a n u la t in g s o lu t io n s

• T h e m o is t u r e c o n te n t a n d r a t e o f m o is t u r e u p ta k e a r e fu n c t io n s o f t e m p e r a t u r e a n d h u m id i t y a n d s h o u ld b e c o n n s id e r e d .

• M o is t u r e c o n te n t in a g r a n u la t io n a f f e c t s th e t a b le t in g c h a r e c t e r is t ic o f t h e g r a n u la t io n ,

• H y g r o s c o p ic i t y d a ta c a n a id in th e d e s ig n o f t a b le t-m a n u fa c t u r in g a r e a s .

• M o is t u r e s e n s i t iv e d r u g s s h o u ld n o t b e c o m b in e d w it h h y g r o s c o p ic e x c ip ie n t s ,

• P a c k a g in g m a te r ia l s h o u ld b e c h o s e n to s u i t t h e p r a d u c t .

Page 16: G oing into detail - MIN | Mohamed Ibrahim NoordinG oing into detail Theoritical C oncept of, Tabletting process, Procedures and C haracteristic. ACTIVE ... The goals in tablet dosage

C o n t… .M o is t u r e C o n te n t a n d U p ta k e b y ta b le t

• M o is t u r e is h e ld in a m a te r ia l e i t h e r in a - b o u n d

o r - u n b o u n d m a n n e r

• T h e c o n d i t io n s u n d e r w h ic h th is w a te r is r e le a s e d f r o m a m a te r ia l s h o u ld b e c o n s id e r e d in th e s e le c t io n o f d i lu e n t s

Page 17: G oing into detail - MIN | Mohamed Ibrahim NoordinG oing into detail Theoritical C oncept of, Tabletting process, Procedures and C haracteristic. ACTIVE ... The goals in tablet dosage

• e g ., C a S u lp h a te d ih y d r a t e h a s 1 2 % m o is t u r e o n a m o le fo r m o le b a s is (b o u n d m o is t u r e a s w a te r o f c r y s t a l l iz a t io n -le b e r a t e d o n ly a t m o r e th a n 8 0 °C) a n d a b s o r p l i t t le m o is t u r e . S o C a S u lp h a te is w id e ly u s e d in v i t . T a b . A n d o th e r m o is t u r e s e n s i t iv e ta b s .

Page 18: G oing into detail - MIN | Mohamed Ibrahim NoordinG oing into detail Theoritical C oncept of, Tabletting process, Procedures and C haracteristic. ACTIVE ... The goals in tablet dosage

O th e r p r o p e r t ie s o f d i lu e n t s to b e c o n s id e r e d

• Degree of Cohesiveness - w h ic h a d i lu e n t im p a r t w h e n c o m p a c t e d e s p . w h e n s iz e o f t a b le t is a l im i t in g fa c t o r

• S ensitivity to Physiochemical c h a n g e s a r is in g f r o m m a n u fa c t u r in g o r p r o c e s s in g

e g ., im p a c t o f a p p l ie d fo r c e (c o m p r e s s io n ) o n d is in t e g r a t io n & h a r d n e s s ~ f ig .3 & 4Ideal property of a diluent ~ not sensitive to physicochemical changes during manufacturing such that it will affect tab. Quality adversely

Page 19: G oing into detail - MIN | Mohamed Ibrahim NoordinG oing into detail Theoritical C oncept of, Tabletting process, Procedures and C haracteristic. ACTIVE ... The goals in tablet dosage

• Cost - per kg• taste & mouth-feel e s p .c h e w a b le ta b le t : w h e r e ”a g in g ” e f f e c t s le a d in g to r e d u c e d c h e w a b i l i t y a n d in c r e a s e h a r d n e s s a r e to b e e x a m in e .

Page 20: G oing into detail - MIN | Mohamed Ibrahim NoordinG oing into detail Theoritical C oncept of, Tabletting process, Procedures and C haracteristic. ACTIVE ... The goals in tablet dosage
Page 21: G oing into detail - MIN | Mohamed Ibrahim NoordinG oing into detail Theoritical C oncept of, Tabletting process, Procedures and C haracteristic. ACTIVE ... The goals in tablet dosage